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Abstract
Background: End stage renal disease (ESRD) is associated with defective T-cell mediated immunity. A diverse T-cell
receptor (TCR) Vβ repertoire is central to effective T-cell mediated immune responses to foreign antigens. In this study,
the effect of ESRD on TCR Vβ repertoire was assessed.
Results: A higher proportion of ESRD patients (68.9 %) had a skewed TCR Vβ repertoire compared to age and
cytomegalovirus (CMV) – IgG serostatus matched healthy individuals (31.4 %, P < 0.001). Age, CMV serostatus and
ESRD were independently associated with an increase in shifting of the TCR Vβ repertoire. More differentiated
CD8+ T cells were observed in young ESRD patients with a shifted TCR Vβ repertoire. CD31-expressing naive T cells and
relative telomere length of T cells were not significantly related to TCR Vβ skewing.
Conclusions: ESRD significantly skewed the TCR Vβ repertoire particularly in the elderly population, which may
contribute to the uremia-associated defect in T-cell mediated immunity.
Keywords: End stage renal disease, T cell receptor Vβ repertoire diversity, Age, Cytomegalovirus–IgG
serostatus, CD28 null T cells
Background
Patients suffering from end stage renal disease (ESRD)
have an impaired T-cell mediated immune system,
characterized by an increased susceptibility for infec-
tions [1], a decreased response to vaccination [2–4] and
a heightened risk for virus-associated cancers [5]. Loss
of renal function is associated with a severe depletion
of naive T cells and a shift to more differentiated mem-
ory T cells [6]. An advanced decline in thymic output
and attrition of telomeres was noted in both CD4+ as
well as CD8+ T cells of ESRD patients [7, 8]. These
uremia-induced effects on T cells closely resemble prema-
ture T-cell aging and revealed a discrepancy of 15–20
years between the patient’s immunological age of their T
cells and their chronological age [7].
A diverse (polyclonal) T cell receptor (TCR) reper-
toire capable of recognizing a broad range of foreign
antigens is key to an effective T-cell-mediated immune
response [9]. Naive T cells migrating from the thymus
into the circulation, carrying CD31 antigen on their cell
surface [10], possess the broadest TCR repertoire (i.e.
polyclonal TCR repertoire) [11]. The memory T cells
that develop upon encountering of an antigen have a
repertoire that is being skewed towards particular spec-
ificities [12] but this does not automatically imply a loss
of TCR diversity. Similarly, although the composition of
the circulating T cells may be profoundly altered in
ESRD patients, it is not known whether this invariably
leads to an oligoclonal TCR repertoire reflecting a lim-
ited capacity to respond to novel encountered antigens.
Most TCRs consist of an α and a β chain and each
chain is composed of a variable (V) region and a con-
stant (C) region. In the thymus, the V region of the
TCR α and β chain is generated by random gene re-
arrangement of variable (V) and joining (J) genes or V,
diversity (D) and J genes, respectively. Contraction of
TCR Vβ repertoire has been reported to occur during
aging, starting from roughly 600 × 103 clonal types
detected per 106 T cells in childhood and declining by
5 × 103 clones per year [13]. The TCR Vβ repertoire
diversity might also be affected by chronic antigenic
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stimulation [14–16]. For example, cytomegalovirus
(CMV) latency may also induce contraction of the TCR
Vβ repertoire as it results in a vast expansion of CMV
specific T cell-exceeding 4 % of CD8+ T cells in im-
munocompetent donors [17] and these anti-CMV T
cells clones were stably maintained for 5 years [18].
CMV-IgG seropositive ESRD patients have shorter telo-
meres within CD8+ T cells and an increased T cell dif-
ferentiation status with higher percentages of CD57+
and CD28− CD4+ and CD8+ memory T cells [19]. Both
CMV latency and ESRD, alone or in combination, may
profoundly alter the composition of the peripheral T
cell compartment [19, 20].
We hypothesized that ESRD may decrease the TCR
Vβ repertoire diversity and that CMV latency could
further add to this loss of diversity. In this study, we
therefore assessed the TCR Vβ repertoire diversity of
ESRD patients relative to age- and CMV-IgG serosta-
tus- matched healthy individuals (HI). The TCR Vβ
repertoire diversity was evaluated by a qualitative
multiplex DNA-based PCR of TCR Vβ-Jβ gene rear-
rangements, originally designed to diagnose lympho-
proliferations [21]. The generated Genescan profile
was used to distinguish between a Gaussian distrib-
uted (diverse or polyclonal) and a more or less skewed
(narrowed or even monoclonally expanded) TCR Vβ
repertoire.
Results
Study population characteristics
The demographic and clinical characteristics of the study
population are given in Table 1. Approximately 45 % of
ESRD patients received renal replacement therapy with
the median dialysis time of 13 months. Twenty-one pa-
tients were within the young group (age 19 – 45 years)
and 24 patients belonged to the elderly group (age 65 –
77 years).
ESRD is associated with a skewed TCR Vβ repertoire
A TCR Vβ repertoire was defined as non-skewed one
when the spectratype of TCR Vβ repertoire on the
Genescan profile showed a Gaussian distribution (Fig. 1a,
left profile) or a skewed one showing an oligoclonal pat-
tern with one (Fig. 1a middle profile) or more clonal
(Fig. 1a, right profile) peak(s) on the Genescan profile. A
skewed (or oligoclonal) TCR Vβ repertoire was present in
a larger (P < 0.001) proportion (68.9 %) of the ESRD pa-
tients compared to HI (31.4 %) (Fig. 1b). Further dividing
the results into single or multiple (oligo)clonal peaks did
not lead to significantly different percentages in skewed
TCR Vβ repertoire between the ESRD patients and HI
(Fig. 1c). Percentages of individuals with multiple (oligo)-
clonal peaks in the skewed TCR Vβ repertoire amounted
to 51.6 and 43.7 % in ESRD patients and HI, respectively
Table 1 Clinical and biological characteristics of the study population
Healthy individuals ESRD Patients P value
Number of individuals 51 45
Age (young/eldely) (years; mean ± SD) 33.1 ± 7.6/68.0 ± 3.0 32.9 ± 9.2 / 68.3 ± 3.5 NS/NSa
Sex (% male) 41.2 68.9 P < 0.05
CMV IgG serostatus (% pos) 52.9 51.1 NS
T cells number in peripheral blood (106/μl; mean ± SD) 1274 ± 304 1164 ± 260 NS
Renal replacement therapy (number; %) 44.4
Duration of Renal replacement therapy (months; median/rang) 13/3-68
Hemodialysis (%) 80.0
Peritoneal dialysis (%) 15.0
Peritoneal dialysis followed hemodialysis (%) 5.0
Underlying kidney disease
Nephrosclerosis/atherosclerosis/hypertensive nephropathy (%) 17.8
Primary glomerulopathy (%) 6.7
Diabetic nephropathy (%) 20.0
Reflux nephropathy (%) 17.8
Polycystic kidney disease (%) 20.0
Other (%) 15.6
Unknown (%) 2.2
Abbreviations: ESRD end stage renal disease, CMV cytomegalovirus, NS not significant
aAge categories of young (≤45 years) and elderly ( ≥65 years) were used
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(P > 0.05). In conclusion, ESRD is associated with skewing
of the TCR Vβ repertoire.
Both Aging and CMV serostatus affect the TCR Vβ
repertoire diversity in ESRD patients
Dissecting the ESRD and healthy study population into
a young and elderly group, revealed significantly more
(P < 0.001) skewing within the elderly ESRD patients
compared to the age-matched HI, proportions were
87.5 % versus 32.0 %, respectively (Fig. 2a). In addition,
an age-related skewing in TCR Vβ repertoire was ob-
served for ESRD patients (P < 0.01), but not for healthy
individuals (Fig. 2a). Moreover, like for the overall study
population, no differences were observed between the
composition of multiple and single oligoclonal peaks in
young and elderly ESRD patients with a skewed TCR
Vβ repertoire (Fig. 2b).
We then looked at the effect of CMV IgG seropositivity
on TCR Vβ repertoire skewing. A skewed TCR Vβ reper-
toire was observed in 41.7 and 16.7 % of CMV-IgG sero-
positive and CMV-IgG seronegative HI, respectively.
Approximately, 91.3 % of CMV-IgG seropositive ESRD pa-
tients had a skewed TCR Vβ repertoire whereas skewing of
the TCR Vβ repertoire occurred in 45.5 % of CMV-IgG
seronegative ESRD patients. CMV latency skewed (P <
0.01) the TCR Vβ repertoire in both HI as well as ESRD pa-
tients (Fig. 2c). Data was further analyzed taking the effect
of aging into account. In young CMV-IgG seropositive and
negative patients, percentage of patients with a skewed
TCR Vβ repertoire amounted to 80.0 and 18.2 %, whereas
in the elderly percentages were 100 % and 72.7 %, respect-
ively (Fig. 2d). A similar trend occurred in the healthy
population, only reaching significance (P < 0.01) in the eld-
erly group (Fig. 2d). Although CMV latency significantly
added to the skewing of the TCR Vβ repertoire in ESRD
patients, the effect of ESRD on the TCR Vβ repertoire
was present in both CMV-seropositive as well as CMV-
seronegative elderly individuals. The percentage of elderly
patients with a skewed TCR Vβ repertoire was signifi-
cantly higher when compared to the CMV-status matched
elderly HI (P < 0.05) (Fig. 2d).
ESRD, aging, and CMV latency influenced the TCR Vβ
repertoire diversity independently
To test the influence of several factors such as ESRD,
aging, CMV latency, and gender (as the percentage of
males was significantly higher in the patients compared to
HI) on skewing of the TCR Vβ repertoire, a binary logistic
Fig. 1 Skewed and non-skewed TCR Vβ repertoire distribution in healthy individuals (HI) and end stage renal disease (ESRD) patients. The different
genescan profiles obtained following spectratyping of the DNA-based multiplexed TCR Vβ PCR samples are depicted in a. This reaction consists
of 23 Vβ primers and 9 Jβ primers. The green profile represents the 6 Jβ primers (Jβ1.1, Jβ1.2, Jβ1.3, Jβ1.4, Jβ1.5, Jβ1.6), whereas the blue line
represents the 3 Jβ primers (Jβ2.2, Jβ2.6, and Jβ2.7) in this multiplex PCR. The red profile represents the internal size standard. The left profile
shows a non-skewed (polyclonal) pattern, the middle one shows a skewed pattern with a single (oligo)clonal peak (size of the oligoclonal
product is 253 nucleotides (nt)) whereas the right panel depicts a skewed pattern with multiple (oligo)clonal peaks (sizes of the oligoclonal
products are 252, 261 and 264 nt, respectively). The arrows indicate oligoclonal peaks within the genescan profile. b Frequency of ESRD pa-
tients (n = 45) and age-matched HI (n = 51) with a skewed (closed squares) and non-skewed (open squares) TCR Vβ repertoire. c Frequency of single
(open squares) and multiple (oligo)clonal peaks (closed squares) within a skewed TCR Vβ repertoire of ESRD patients (n = 31) and HI (n = 16). P value: *
<0.05; ** < 0.01; *** < 0.001; NS: not significant
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regression model was used. Except for gender (P >
0.05), ESRD (P < 0.05, odds ratio (OR) = 4.8), age (P <
0.05, OR = 2.3) and CMV-IgG seropositivity (P < 0.05,
OR = 6.7) were significantly associated with skewing of
TCR Vβ repertoire. A multiple binary logistic regression
model was used to further analyze whether the effects on
TCR Vβ repertoire skewing were independent. ESRD (P <
0.05, OR =10.2), age (P < 0.05, OR =3.1) and CMV-IgG
seropositivity (P < 0.05, OR =13.8) remained significant,
indicating these factors to independently contribute to
skewing of the TCR Vβ repertoire. CMV-IgG seropositiv-
ity contributed mostly to the skewing of the TCR Vβ rep-
ertoire followed by ESRD and age (Table 2). In the ESRD
patients, neither renal replacement therapy (RRT) (P >
0.05) nor underlying kidney disease (P > 0.05) were associ-
ated with skewing of the TCR Vβ repertoire (Table 2).
Skewed TCR Vβ repertoires are presented predominantly
within the CD8+ memory T cell subset and is associated
with more differentiated T cells
In order to determine whether skewing of TCR Vβ was
associated with specific T cell subsets, CD4+/CD8+ naive
and CD4+/CD8+ memory T cells from ten elderly
healthy individuals (of which 50 % were CMV seroposi-
tive) as well as 10 elderly ESRD patients (also containing
50 % CMV-seropositive individuals) were FACS-sorted.
Skewing of the TCR Vβ repertoire significantly oc-
curred in CD8+, but not CD4+, memory T cells in eld-
erly ESRD patients only (Table 3). Within the CD8
memory T cells, a skewed TCR Vβ repertoire was ob-
served in 5 CMV-seropositive and 4 CMV-seronegative
elderly ESRD patients.
The ratio of CD4+/CD8+ T cells was significantly
lower in young and elderly ESRD patients with a
skewed TCR Vβ repertoire compared to age-matched
ESRD patients without skewed TCR Vβ repertoire, re-
spectively (young: 1.73 versus 2.38 P < 0.05; elderly:
2.30 versus 4.71, P < 0.05). Next, we determined the
association between having a skewed TCR Vβ reper-
toire and T cell subsets as well as the differentiation
status of T cells. In Fig. 3a, a typical flow cytometric
example of the gating strategy for dissecting the differ-
ent CD4+ T-cell subsets including naive, central mem-
ory (CM), effector memory (EM), highly differentiated
Fig. 2 Skewed and non-skewed TCR Vβ repertoire distribution in healthy individuals (HI) and end stage renal disease (ESRD) patients dissecting
the population into subgroups according to age and CMV-IgG serostatus. a Frequency of a skewed TCR Vβ repertoire in young (n = 21) and
elderly (n = 24) ESRD patients compared to age- matched HI (young, n = 26 and elderly, n = 25). b Frequency of multiple (oligo)clonal peaks
within a skewed TCR Vβ repertoire of young (n= 10) ESRD patients compared to elderly ESRD patients (n= 21). c Frequency of a skewed TCR Vβ repertoire
in CMV-IgG seropositive (n = 23) and seronegative (n = 22) ESRD patients, compared to CMV-IgG seropositive (n = 27) and seronegative (n = 24)
healthy individuals. d Frequency of a skewed TCR Vβ repertoire in young ESRD patients with CMV- IgG seropositive status (n = 10) or CMV-IgG
seronegative status (n = 11) and elderly ESRD patients with CMV-IgG seropositive status (n = 13) or CMV-IgG seronegative status (n = 11), compared to
age-matched CMV-IgG seropositive (young n = 14, elderly n = 13) and CMV IgG seronegative (young n = 12, elderly n = 12) HI. The closed
squares represent skewed or multiple oligo(clonal) peaks within skewed TCR Vβ repertoires whereas the open squares represent non-skewed or single
(oligo)clonal peaks within skewed TCR Vβ repertoires, respectively. P value: * <0.05; ** < 0.01; *** < 0.001; NS: not significant
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effector memory (EMRA) as well as for determining
the differentiation status of the T-cell compartment by
analysis of CD28− T cells is given. A similar approach
was also employed for CD8+ T cells. Young ESRD pa-
tients with a skewed TCR Vβ repertoire had increased
numbers of more differentiated memory T cells, i.e.
EMRA (Fig. 3n) as well as CD28−CD8+ T cells (Fig. 3o).
The number of individuals without skewing in the eld-
erly ESRD patients was limited (only 3 out of 24),
which might explain why the comparison between
non-skewed and skewed ESRD patients did not reach
significance for CD8 EMRA or CD8 CD28- T cells but
similar trends were observed (Fig. 3n & o). Approxi-
mately 80 % of the young and 62 % of the elderly
ESRD patients, that had a skewed TCR Vβ repertoire,
were CMV-seropositive, confirming the previously de-
scribed effects of CMV-latency on the T cell compart-
ment. Moreover, the skewed TCR Vβ repertoire was
correlated with more differentiated CD8+ T cells in
the healthy population as well. In the elderly healthy
individuals, those with a skewed TCR Vβ repertoire
had more CD8+ T cells, more CD8+ memory, CD8+
EMRA and CD8+CD28− than the individuals without
skewed TCR Vβ repertoire (Additional file 1: Figure
S1 H, J, M, and N). Within young healthy individuals,
the numbers of CD8+ memory (MEM), CD8+ effector
memory (EM) and CD8+CD28− T cells were signifi-
cantly higher in the individuals with skewed TCR rep-
ertoire than the individuals with a polyclonal TCR Vβ
repertoire (Additional file 1: Figure S1 J, L, N). The pro-
portions of CMV-IgG seropositive individuals within the
HI with a skewed TCR repertoire amounted to 75 % and
100 % in young and elderly HI, respectively.
Number of CD31+ naive T cells and relative telomere
length (RTL) are not correlated to a skewed TCR Vβ
repertoire
Thymic output, assessed by number of CD31-expressing
naive CD4+ and CD8+ T cells (Fig. 4a), was not different
for ESRD patients or healthy individuals with and with-
out a skewed TCR Vβ repertoire. Remarkably, only eld-
erly patients and HI with a skewed TCR Vβ repertoire
Table 2 The variables related to a skewed TCR Vβ repertoire
Non-skewed TCR Vβ Skewed TCR Vβ Odds ratio P value
Age (years, median) 41 65 3.1a < 0.05
% of CMV seropositivity 30.7 74.5 13.8b < 0.05
% of ESRD patients 28.6 70.0 10.2c < 0.05
% of patients on renal replacement therapy 35.8 48.4 NS
Underlying kidney disease (number)
Nephrosclerosis/atherosclerosis/hypertensive nephropathy 1 7 NS
Primary glomerulopathy 0 3 NS
Diabetic nephropathy 2 7 NS
Reflux nephropathy 4 4 NS
Polycystic kidney disease 2 7 NS
Other 5 2
Unknown 0 1
Abbreviations: TCR T cell receptor, NS not significant
ameans the odds of a skewed TCR Vβ repertoire in elderly population is 3.1 times higher than in the young population
bmeans the odds of a skewed TCR Vβ repertoire in CMV- IgG seropositive population is 13.8 times higher than in the CMV- IgG seronegative population
Cmeans the odds of a skewed TCR Vβ repertoire in patients is 10.2 times higher than in the healthy individuals
Table 3 Frequency of elderly individuals with skewed and non-skewed TCR Vβ repertoire in the sorted T cells subsets
T cell
subsets
HI ESRD patients
Skewed Non-skewed P value Skewed Non-skewed P value
CD4 naive 0a 10 NS 0 10 NS
CD4 Memory 2 8 3 7
CD8 Naive 3 7 NS 3 7 < 0.05
CD8 Memory 7 3 9 1
Abbreviations: TCR T cell receptor repertoire, ESRD end stage renal disease, HI healthy individuals, NS not significant
aData are shown as the numbers of individuals
Huang et al. Immunity & Ageing  (2015) 12:28 Page 5 of 11
showed an age-related decline in CD31+ naive CD4+ T
cells (Fig. 4b and Additional file 1: Figure S2A). An age-
related decline in CD31+ naive CD8+ T cells was ob-
served in both patients and HI (Fig. 4c and Additional
file 1: Figure S2B). Another hallmark of T cell ageing is
attrition of telomeres and a typical example of the flow
cytometric analysis of telomere length is shown in
Fig. 4d. Assessing the association of this parameter to
skewing of the TCR Vβ repertoire only revealed a trend
to shorter telomeres in CD8+ (Fig. 4f ) T cells of elderly
ESRD patients with a skewed TCR Vβ repertoire com-
pared to those without. The RTL of CD4+ /CD8+ T cells
Fig. 3 (See legend on next page.)
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were not significantly different between the healthy indi-
viduals with and without a skewed TCR repertoire either
(Additional file 1: Figure S2 C&D).
Discussion
The main observation of this study is that ESRD inde-
pendently skews the TCR Vβ repertoire. In combination
with an older age and CMV seropositivity, this leads to
a skewed TCR repertoire in almost all elderly ESRD pa-
tients. This finding extends the knowledge that loss of
renal function is associated with significant changes in
several T-cell (aging) parameters such as thymic output,
T-cell differentiation status and proliferative history as
analyzed by relative telomere length analysis [6, 7]. In
contrast with these studies that demonstrate effects of
ESRD on various T-cell parameters over a broad age
range, skewing of the TCR Vβ repertoire by ESRD is
limited to the elderly, which indicates that young ESRD
patients are still able to maintain a relatively diverse
TCR Vβ repertoire.
In our study, we tested all TCR Vβ gene families, in a
multiplex DNA-based approach and considered differ-
ent variables possibly influencing TCR Vβ repertoire di-
versity, like age [13, 22], CMV-serostatus [17], gender
[23], ESRD, RRT and underlying kidney disease [24, 25].
Although CMV was the strongest factor amongst the
examined variables, affecting both the young and eld-
erly ESRD patients as well as elderly HI, ESRD seems
to introduce skewing in both the CMV-seronegative as
well as CMV-seropositive elderly group. We only ob-
served an age-related effect on TCR Vβ skewing in our
ESRD patient population, but aging alone does not
seem to significantly compromise TCR Vβ skewing. It is
also reported that the TCR-Vβ repertoire of CD8+ T
cells was already skewed in young CMV-seropositive
HI and did not modulate further with age [26]. Also,
Sunder-Plassmann et al. [27] showed ESRD patients re-
ceiving hemodialysis treatment to have a skewed TCR
Vβ repertoire, with an impressive increase of TCR Vβ6.7
and a massive deletion of the TCR Vβ8 in peripheral blood
lymphocytes compared to healthy controls. In our study,
we were unable to find a significant association between
RRT and skewing of the TCR Vβ repertoire. This is in ac-
cordance with our previous findings, which did show a
significant effect of ESRD on ageing of the peripheral T
cells but hardly any differences between patients with
or without RRT. [8] Gender also did not affect TCR Vβ
skewing and in agreement with the research by Sunder-
Plassmann et al. [27], we did not find a significant con-
tribution of underlying kidney disease with respect to
skewing of the TCR Vβ repertoire. This might indicate
that the chronic inflammatory milieu [28] in which the
T cells circulate and the significant changes in the per-
ipheral T cell compartment [6] as a consequence of the
loss of renal function causes oligoclonality of the TCR
repertoire.
A skewed TCR Vβ repertoire is associated with sig-
nificant changes in composition of peripheral T cells
and related to a highly differentiated pattern. A skewed
TCR Vβ repertoire in HI was correlated to an increased
number of highly differentiated memory CD8+ T cells.
This might be due to the fact that most of the healthy
individuals with a skewed TCR Vβ repertoire were
CMV-seropositive. CMV latency introduces significant
changes in the peripheral T cell compartment, in par-
ticular affecting CD8+ T cells [29] and is known to
introduce skewing of the TCR Vβ repertoire as a result
of expansion of CMV-specific T cell clones in the HI
[17]. In refractory cytopenia patients, TCR Vβ skewing
correlates with an expansion of effector CD8+ T cells
[30]. A similar correlation between a skewed TCR Vβ
repertoire and an increased number of highly differenti-
ated memory CD8+ T cells was also found in young
ESRD patients and tended to be significant in the eld-
erly patients. Also within ESRD patients, a large pro-
portion was CMV-IgG seropositive, highlighting the
possibility that skewing of TCR Vβ repertoire may be
likewise related to clonal expansions of antigen-specific
T cells directed to CMV or expansion of other TCR-
specificities, e.g. TCR Vβ 6.7 as reported before [27].
CD31-expressing naive T cells have undergone a lower
number of cell divisions [10] and have a broader TCR Vβ
(See figure on previous page.)
Fig. 3 Absolute number of circulating CD4+ and CD8+ T cell subsets in young (n = 10) and elderly end stage renal disease (ESRD) patients (n = 21)
with a skewed TCR Vβ repertoire compared to age-matched ESRD patients without a skewed TCR Vβ repertoire (young n = 11; elderly n = 3). A typical
example of the gating strategy for dissection of the different T cell subsets by flow cytometry following a whole blood staining protocol is
given in a. Briefly, lymphocytes were identified based on the forward/sideward characteristics followed by the selection of CD3+ T cells. These
CD3+ T cells were then dissected into CD4+ and CD8+ T cells. CCR7 and CD45RO were used to identify the CD4+ T cells subsets. Furthermore,
CD28− T cells were examined within the total CD4+ population. A similar gating strategy was employed for determination of absolute numbers of CD8+ T
cell subsets and the differentiation status. The number of (b) CD4+, (c) CD4+ naive, (d) CD4+ total memory, (e) CD4+ central memory (CM), (f) CD4+ effector
memory (EM), (g) CD4+ highly differentiated effector T cells (EMRA), (h) CD4+CD28− T cells, as well as (i) CD8+, (j) CD8+ naive, (k) CD8+ total memory, (l)
CD8+ central memory (CM), (m) CD8+ effector memory (EM), (n) CD8+ highly differentiated effector T cells (EMRA) and (o) CD8+CD28− T cells are
shown. Data are given as median with interquartile range. The open bars represent ESRD patients with a non-skewed TCR Vβ repertoire and closed
bars correspond to ESRD patients with a skewed TCR Vβ repertoire. P value: * < 0.05; ** < 0.01; *** < 0.001; NS: not significant
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Fig. 4 (See legend on next page.)
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repertoire than those lacking CD31 [11]. Some clones
could be lost during naïve T cell homeostatic proliferation
[31], as a massive deletion of the TCR Vβ8 was observed
in peripheral blood lymphocytes of hemodialysis patients
[27]. However, the numbers of CD31- expressing naïve T
cells were not significantly different between the patients
with skewed and non-skewed TCR Vβ repertoire. In
addition, the skewed TCR Vβ repertoire was predomin-
antly observed in the sorted CD8+ memory compartment
and not in naïve T cells. This implies that some memory
T-cell clones proliferate more efficiently in response to the
ESRD associated pro-inflammatory environment or anti-
genic stimulation such as CMV. Clonal expanded CD8+ T
cells are also observed in the peripheral blood of multiple
sclerosis patients. Based on the current findings, we plan
to conduct a more in depth analysis of the TCR Vβ reper-
toire including both the diversity (the number of specific
clones) and the relative abundance of particular clones
(the number of reads per clone). The clinical implications
of having a skewed or less diverse TCR Vβ repertoire prior
to kidney transplantation are not yet explored. However,
analysis of TCR Vβ repertoire diversity following trans-
plantation has been the subject of several studies [32, 33].
Miqueu et al. [34] reported a skewed repertoire to be re-
lated to an increased risk of humoral chronic rejection
after kidney transplantation. It might be of interest to in-
vestigate the consequences of a skewed TCR Vβ repertoire
before kidney transplantation with respect to clinical out-
comes following kidney transplantation like rejection epi-
sodes or to examine whether this TCR Vβ repertoire
would change after kidney transplantation.
Conclusions
ESRD significantly and independently skews the TCR Vβ
repertoire in the elderly individuals and this skewed
TCR Vβ pattern is associated with more differentiated T
cells subsets. Assessing the TCR Vβ repertoire diversity
in more detail will increase our knowledge with respect
to the defective T-cell mediated immunity observed in
ESRD patients and will allow to evaluate its clinical rele-
vance with respect to transplantation.
Methods
Study population
Forty-five stable adult ESRD patients, defined as a glom-
erular filtration rate of ≤ 15 ml/min with or without
hemodialysis, on the waiting list for the first kidney
transplantation and 51 healthy kidney donors were in-
cluded (Table 1) from 1st November 2010 to 1st October
2013 in nephrology department of Erasmus medical cen-
ter. Patients with any clinical or laboratory evidence of
acute bacterial or viral infection, malignancy, previous
kidney transplantations, immunosuppressive drugs treat-
ment within 28 days prior to transplantation (except glu-
cocorticoids) were excluded. Age, CMV-IgG serostatus
and total T-cell number in the peripheral blood were
matched between these two groups. Lithium-heparinized
blood was drawn prior to transplantation of ESRD pa-
tients and healthy kidney donors. All individuals in-
cluded gave informed consent and the local medical
ethical committee approved the study (METC number:
2012–022). It was conducted according to the principles
of Declaration of Helsinki and in compliance with Inter-
national Conference on Harmonization/Good Clinical
Practice regulations.
Circulating T cell numbers and their differentiation status
Freshly drawn peripheral blood samples from 45 ESRD
patients and 51 healthy individuals (HI) were stained
and acquired on a FACSCanto II flow cytometer (BD
Biosciences, Erembodegem, Belgium) as described previ-
ously [7, 35] to determine both frequencies and absolute
numbers of the different T cell subsets as well as their
differentiation status. Data were analyzed using FACS
Diva software version 6.1.2 (BD Biosciences). Detailed
methods can be found in the Additional file 1: Methods
section.
PBMCs isolation, DNA isolation and TCR Vβ repertoire
analysis
PBMCs from 45 ESRD patients and 51 healthy individuals
(HI) were isolated from peripheral blood as described previ-
ously [3]. One million PBMCs were snap-frozen for DNA
isolation and the remaining were frozen at 10 million per
(See figure on previous page.)
Fig. 4 Absolute number of CD31-expressing naive CD4+ and CD8+ T cells and relative telomere length (RTL) of CD4+ and CD8+ T cells in end
stage renal disease (ESRD) patients with skewing in TCR Vβ repertoire compared with age-matched ESRD patients without skewing in TCR Vβ
repertoire. A typical flow cytometric example of the analysis of CD31-expression within naive CD4+ (left histogram) and CD8+ (right histogram)
T cells (identified as depicted within Fig. 3a) is given in a. The number of CD31+ (b) CD4+ and (c) CD8+ naive T cells for young and old ESRD
patients with a non- (open bars; young n = 11, elderly n = 3) and skewed (closed bars; young n = 10, elderly n = 21) TCR Vβ repertoire are given.
In d, a typical flow cytometric example is depicted of the analysis to allow for the determination of relative telomere length (RTL). Histograms
showing the median fluorescence intensity (MFI) of the FITC-channel of samples incubated without (unfilled peak) and with the FITC-labelled
PNA-probe (filled peak) are shown for the CCRF-CEM 1301 subcell-line (left panel) and CD4+ (right panel), respectively. The RTL of (e) CD4+ and
(f) CD8+ T cells are shown. Triangles represent the RTL of ESRD patients with a non-skewed TCR Vβ repertoire (young = 8, elderly n = 3) and
squares correspond to ESRD patients with a skewed TCR Vβ repertoire (young n = 6, elderly n = 19). Data are given as median with interquartile
range. * < 0.05; ** < 0.01; *** < 0.001; NS: not significant
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vial until further use. DNA was isolated according to manu-
facturer’s instructions (QIAamp DNA Mini QIAcube Kit).
The TCR Vβ gene repertoire was measured by the multi-
plex TCR Vβ-Jβ gene PCR as developed and approved by
the European consortium of 45 laboratories (BIOMED-
2 Concerted Action BMH4-CT98-3936) [21]. The term
skewed TCR Vβ repertoire was used when the TCR Vβ
showed an oligoclonal pattern with one or more clonal
peak(s) on the Genescan profile and the term non-
skewed Vβ repertoire was used when the spectratype of
TCR Vβ repertoire on the Genescan profile showed a
Gaussian distribution [21].
Sorting of T cell subsets
Cryopreserved PBMCs were thawed, washed and resus-
pended in PBS. The PBMCs from ten elderly patients (of
which 50 % were CMV-seropositive) and 10 elderly healthy
individuals (of which 50 % were CMV-seropositive) were
stained and subsequently sorted into T cells subsets i.e.
CD4+ naive/memory and CD8+ naive/ memory using flow
cytometry based cell-sorting (BD FACSAria™ II SORP, BD).
A typical example of the gating strategy to dissect the
different T cell subsets prior to sorting as well as the
analysis of the purity of the sorted samples was given in
Additional file 1: Figure S3. The purity of all T cell sub-
sets was over 95 %. The details for flow cytometry-
based cell-sorting of T cell subsets are given in the
Additional file 1: Methods section.
Telomere length assay
Flow fluorescent in situ hybridization was performed to
determine the relative telomere length (RTL) of T cells
as described previously [7, 35]. Detailed information is
given in the Additional file 1: Methods section.
Statistical analyses
Statistical analyses were performed using SPSS 20 (IBM,
Chicago, IL, USA) and GraphPad Prism 6 (GraphPad Soft-
ware, Inc., La Jolla, CA, USA). Categorical variables were
compared using the chi-square test or Fisher’s exact
test. Continuous variables were compared using Mann–
Whitney U-test. Binary logistic regression was used to
estimate the probability that skewing of TCR repertoire
was present given the values of explanatory variables.
All reported P-values are two-sided and were consid-
ered statistically significant when P < 0.05.
Additional file
Additional file 1: Figure S1. Absolute number of circulating CD4+ and
CD8+ T cells in young (n = 8) and elderly healthy individuals (HI, n = 8)
with skewing in TCR Vβ repertoire compared to age-matched HI without
skewing in TCR Vβ repertoire (young n = 18; elderly n = 17). Figure S2.
Absolute number of CD31-expressing naive and relative telomere length
(RTL) of CD4+ and CD8+ T cells of healthy individuals (HI) with skewing in
TCR Vβ repertoire compared to age-match HI without skewing in TCR Vβ
repertoire. Figure S3. A typical example of the gating strategy to dissect
the different T cell subsets prior to sorting (A) and the analysis of the
purity of CD4+ naive/memory sorted samples (B). Supplementary mate-
rials and methods. (PDF 83890 kb)
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